JOHNSON & JOHNSON is 511.9x more valuable than MANNKIND CORP by market capitalization ($574.10 B vs $1.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MNKD | JNJ |
|---|---|---|
| Market cap | $1.12 B | $574.10 B |
| US-listed rank | #2555 | #20 |
| Revenue (latest FY) | $348.97M | $94.19B |
| Net income (latest FY) | $5.86M | $26.80B |
| Net margin | 1.7% | 28.5% |
| P/E (trailing FY) | 191.3 | 21.4 |
| SEC filings | 1,648 | 984 |
JOHNSON & JOHNSON is 511.9x more valuable than MANNKIND CORP by market capitalization ($574.10 B vs $1.12 B).
In their latest fiscal years, MANNKIND CORP reported $348.97M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: MANNKIND CORP and JOHNSON & JOHNSON, or browse the full rankings.